Skip to content

Repair

All peptides
Blend

Glow

Also known as: Glow blend, GHK-Cu / BPC-157 / TB-500

Adds GHK-Cu's gene-expression and collagen action on top of the Wolverine repair pair, for aesthetics plus deep-tissue recovery. All three are pH-compatible; the triple combo has no RCT of its own.

Reviewed 2026-05-27

What it does

Glow stacks three complementary regenerative peptides in one fixed-ratio vial. GHK-Cu contributes gene-expression modulation, collagen/elastin synthesis, anti-inflammation, and bioavailable copper delivery; BPC-157 contributes angiogenesis, fibroblast proliferation, and GH-receptor upregulation; TB-500 contributes actin-driven cell migration and anti-inflammatory cytokine modulation. The combination is aimed at goals that span soft-tissue repair, anti-aging, and accelerated wound healing simultaneously. The guide lists GHK-Cu + BPC-157 (± TB-500) as pH-compatible, which is the basis for co-injecting them as a single product.

Used for

Dose

Dose
1,670 mcg · 7 days/week (10 units of a 50/10/10 mg vial)
When
EveningEvening dosing is commonly preferred so the regenerative window aligns with overnight tissue repair, mirroring GHK-Cu's standalone timing.
How long
2 months on / 1 month off
Site
subcutaneous
Food
any

Need exact volumes? Open the peptide calculator →

⚠ Caution

  • Active malignancy (theoretical angiogenesis/cell-migration concern — applies to GHK-Cu, BPC-157, and TB-500)
  • Wilson's disease and other copper-metabolism disorders (GHK-Cu)
  • Known copper sensitivity (GHK-Cu)
  • Active sepsis (avoid TB-500 — immunomodulatory)
  • Pregnancy and breastfeeding (no human safety data for any component)
  • Competitive athletes — BPC-157 and TB-500 are on the WADA prohibited list
  • Hypersensitivity to peptide formulations or excipients

Will it work for me?

Establish a baseline (2–3 readings over 1–2 weeks before starting), then track at consistent intervals.

Blood markers
  • Tier 2 — Human observationalhs-CRP / ESR↓· 6–12 weeksInflammation overlay, not a direct action marker.
Functional & psychometric
  • Tier 3 — Animal / in vitroRegion-specific function score (DASH / KOOS / ODI) + standardized skin/wound photography↑· 6–12 weeksTrack function for the repair indication; standardized photography for the aesthetic indication.
  • Tier 3 — Animal / in vitroPain scale (VAS / NPRS)↓· 2–4 weeks

Your stack

Track this peptide in your protocol — dose, schedule, vials on hand, refill projection. Stays in your browser; no account needed.

Add to my stack

Use this peptide

Featured in protocols
Cycling

2 months on, 1 month off.

Related peptides

What's in this blend

  • GHK-Cu50 mg/vial· 71%gene-expression modulation, collagen/elastin, copper delivery
  • BPC-15710 mg/vial· 14%angiogenesis, fibroblast proliferation, GHR upregulation
  • TB-50010 mg/vial· 14%actin sequestration, cell migration, anti-inflammatory
Reconstitution & storage
VialBAC waterConcentrationShelf life
70 mg3 mL1.67 mg / 330 mcg / 330 mcg per 10 units (50/10/10 mg blend)20 days

Standard blend vial is 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500. Reconstitute with 3 mL BAC water for ~1.67 mg / 330 mcg / 330 mcg per 10 units; the vial lasts ~20 days at 10 units/day. Evening dosing is common to align with the overnight repair phase.

Storage. Lyophilized: refrigerate, multi-year stability. Reconstituted: refrigerate 2–8 °C, use within ~20 days. Copper-bound GHK complex is stable; standard handling applies.

Open the peptide calculator →

Nasal delivery

Not suitable for nasal delivery. No established nasal protocol; GHK-Cu and TB-500 systemic/deep-tissue effects require SQ delivery.

Monitoring & questions

Reported side effects
  • Injection site reactions
  • Transient flushing or taste changes (GHK-Cu, anecdotal)
  • Mild fatigue reported anecdotally (BPC-157)
  • No long-term human safety data for the combination — flag explicitly
Biomarkers Juno tracks

Reference

How it works

Each peptide targets a distinct-but-overlapping pathway: GHK-Cu resets gene expression toward a more youthful profile and builds extracellular matrix, BPC-157 drives angiogenesis and cytoprotection, and TB-500 mobilizes cells and damps inflammation. GHK-Cu also adds a nerve-regeneration component (preclinical) the repair pair lacks. The triple combination is used clinically on the strength of the individual peptides' evidence; no large RCT validates the triple combination itself.

EvidenceTier 3 — Animal / in vitro

Tiers are per indication. The same molecule can be Tier 1 for one use and Tier 4 for another — the tier reflects published literature, not community framing.

Comprehensive recovery from injury, surgery, or hard training

Tier 3high confidence

Combines GHK-Cu's matrix/anti-inflammatory action with the BPC-157 + TB-500 repair pair. Mechanistically coherent and supported by each component's preclinical/human-topical literature; no combination RCT.

Pickart L et al. 2018Sikiric P et al. 1993Goldstein AL et al. 2012

Combined anti-aging and tissue repair / skin quality

Tier 3high confidence

GHK-Cu has Tier 1–2 human evidence for TOPICAL skin aging; injectable systemic GHK-Cu and this triple blend have no human RCTs, so the blend's systemic aesthetic claim is Tier 3. Do not transfer GHK-Cu's topical tier to the injectable blend.

Pickart L et al. 2018

Wound healing where speed and quality both matter

Tier 3medium confidence

All three components accelerate re-epithelialization and matrix remodeling in animal/in-vitro models. Mechanistic plausibility is strong; controlled human combination data is absent.

Sikiric P et al. 1993Goldstein AL et al. 2012
Citations (3)
  1. [1]
    Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
    Pickart L, Margolina A · International Journal of Molecular Sciences · 2018 · PMID 29960541
    GHK-Cu gene-expression / collagen / anti-inflammatory anchor for the blend. Note: GHK-Cu's strong human evidence is topical; injectable blend use stays Tier 3.
    View source
  2. [2]
    A new gastric juice peptide, BPC: stomach-stress-organoprotection hypothesis (BPC-157 tissue repair)
    Sikiric P, Petek M, Rucman R, et al. · Journal of Physiology Paris · 1993
    BPC-157 preclinical tissue-repair anchor for the blend.
    View source
  3. [3]
    Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications
    Goldstein AL, Hannappel E, Sosne G, Kleinman HK · Expert Opinion on Biological Therapy · 2012
    TB-500/Thymosin β4 cell-migration and anti-inflammatory anchor for the blend.
    View source